GlobalData
GlobalData

Medical Devices

COVID-19 pandemic impacting robotic surgical systems market with 7.7% lost revenue expected in 2020

Nearly 8% of revenue from robotic surgical systems will be lost in 2020 due to COVID-19, according to GlobalData, a leading data and analytics company, as many elective robotic surgical procedures have been postponed. Given that Intuitive Surgical is the market leader for robotic surgical systems sales, most revenue lost during the COVID-19 pandemic will be experienced by this company. For […]
Read more

TachoSil acquisition gives Corza Health significant foothold in tissue sealants market, says GlobalData

Takeda Pharmaceutical has recently agreed to sell TachoSil Fibrin Sealant Patch to California-based Corza Health for EUR350m (US$413m). The acquisition will provide Corza Health a significant foothold in the growing tissue sealants market, says GlobalData, a leading data and analytics company. TachoSil divestiture is in line with Takeda’s goal of exiting non-core businesses, lowering debt […]
Read more

As schools open, US ramps up COVID-19 testing, says GlobalData

Following the National Institute of Health’s (NIH) awarding of over $100m to increase COVID-19 testing; James Spencer, Data Scientist at GlobalData, a leading data and analytics company, offers his view on the current approach to reopening schools in the US: “As the US passes six million COVID-19 cases, while its citizens move relatively freely, it […]
Read more

Increasing use in home care settings to drive pulse oximeters growth in India, says GlobalData

The necessity to monitor the blood oxygen levels of asymptomatic and mildly symptomatic COVID-19 patients undergoing home isolation and proactive use by the common public in home care-settings are driving the demand for pulse oximeters in India, says GlobalData, a leading data and analytics company. GlobalData’s report, ‘Pulse Oximeter Systems (Anesthesia and Respiratory Devices) – […]
Read more

Convalescent plasma EUA an important step towards COVID-19 treatment, says GlobalData

Following news that the United States Health and Human Services (HHS) received emergency use authorisation (EUA) from the Food and Drug Administration (FDA) for treating COVID-19 patients using convalescent plasma; Brian Hicks, Medical Analyst at GlobalData, a leading data and analytics company, offers his view: “This authorization comes at a time when currently existing COVID-19 […]
Read more

Abbott’s FDA approval for ICD and CRT-D places company in advantageous position over competitors

Abbott won FDA approval in July for its next-generation Gallant implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices, which was equipped with Bluetooth technology and an accompanying smartphone app. This approval places Abbott in an advantageous position over other devices and may allow the company to recover faster from the impact of the […]
Read more
1 39 40 41 42 43 51